85% of EU citizens believe vaccines are an effective way of preventing diseases, but almost half of them think vaccines "can often produce severe side-effects," according to a new Eurobarometer survey.
Combination vaccines represent a substantial outcome of a successful R&D to ease vaccination experience for everyone: children, parents and healthcare professionals while improving the protection of the public against vaccine-preventable diseases.
The European Commission may be planning to hike spending for its flagship research programme, but health and scientific research, particularly into new vaccines, was not one of the winners from the proposal announced on Thursday (7 June).
An innovation-driven approach – ranging from vaccination to other health management solutions and appropriate biosecurity measures – will ensure more sustainable future livestock farming and protection of public health, as animal diseases do not recognise borders, Roxane Feller told EURACTIV.com.
If the scientific community sticks together and makes a coordinated effort, it can be very influential in shaping national vaccination plans, Italian professor Paolo Bonanni told EURACTIV.com, citing Italy as a prime example.
The European Commission could play a decisive role in further harmonising the regulatory framework of vaccines and therefore avoid delays in the supply of vaccines in case of shortages or emergencies, Vaccines Europe told EURACTIV.com.
Public health authorities at EU and national level have started working to “occupy more of the space on social media”, as it is currently almost entirely taken up by people who are against vaccination, Dr Andrea Ammon told EURACTIV.com in an interview.
Parents have a particular responsibility to protect their children, as they are more vulnerable to infections, but vaccination should be seen as a lifelong approach that applies to adults too, centre-right MEP Renate Sommer told EURACTIV.com.
An electronic immunisation record system, which aims to better monitor vaccination among populations, will need clear privacy rules and individuals should be the owners of their own data, Patricia Massetti told EURACTIV.com in an interview. Patricia Massetti is an associate...
The European Commission supports the creation of an electronic immunisation record system that will help EU member states enhance their cross-border cooperation and simultaneously enhance prevention of infectious diseases.
The EU is analysing the aid funding gap left by Donald Trump’s decision to ban US federal funding for NGOs providing birth control support or abortions in developing countries, Development Commissioner Neven Mimica told EURACTIV.com in an exclusive interview.
Whether or not Donald Trump is taking part in efforts to protect the planet, inventions and technological progress are filling an important gap and the EU is playing a role bigger than generally assumed, writes Eli Hadzhieva.
A bright idea turned into reality: vaccines are getting to where they are needed, even in the most remote places in several African countries, thanks to specialised refrigeration support from Coca-Cola.
The European Commission has endorsed Romania’s decision to temporarily suspend exports of measles, mumps and rubella (MMR) vaccine to the rest of the EU, following a serious measles outbreak and dwindling medical stocks. EURACTIV Romania reports.
The Vaccine Alliance has announced that it will fund research into an Ebola vaccine. Without public funding, laboratories often ignore illnesses that affect the poorest patients. EURACTIV France reports.
Over the next 35 years, multidrug-resistant tuberculosis will kill 75 million people and could cost the global economy a cumulative $16.7 trillion (€15.3 trillion) - the equivalent of the European Union's annual output, a UK parliamentary group said on today (24 March).
Vaccination may be the most effective public health intervention of all time. This is especially true in developing countries, where many families can’t find or afford health care when they get sick. The prevention offered by vaccines can be life-saving.
SPECIAL REPORT: Indonesia is developing its own vaccines to fight infectious diseases because funds from the EU and other development agencies to its health sector are drying up. EURACTIV reports from Indonesia.